Dashboard
Manage Tickers

BCLIBRAINSTORM CELL THERAPEUTIC...

Nasdaq brainstorm-cell.com


$ 0.53 $ 0.01 (0.95 %)    

Monday, 29-Apr-2024 15:48:43 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.04 $ 1.75 (0.41 %)
DIA $ 383.81 $ 1.49 (0.39 %)
SPY $ 510.06 $ 1.80 (0.35 %)
TLT $ 88.99 $ 0.74 (0.84 %)
GLD $ 216.18 $ -0.44 (-0.2 %)
$ 0.5396
$ 0.53
$ 0.00 x 0
$ 0.00 x 0
$ 0.53 - $ 0.53
$ 0.13 - $ 3.34
80,513
na
23.24M
$ 1.27
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-28-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 04-26-2021 03-31-2021 10-Q
13 02-04-2021 12-31-2020 10-K
14 10-15-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-07-2020 03-31-2020 10-Q
17 02-18-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-29-2019 12-31-2018 10-K
22 10-29-2018 09-30-2018 10-Q
23 07-23-2018 06-30-2018 10-Q
24 05-14-2018 03-31-2018 10-Q
25 03-08-2018 12-31-2017 10-K
26 10-17-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-29-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-09-2016 12-31-2015 10-K
34 11-16-2015 09-30-2015 10-Q
35 08-13-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-26-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-12-2014 06-30-2014 10-Q
40 05-13-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-brainstorm-cell-therapeutics-announces-management-changes-as-it-plans-registrational-phase-3b-trial-of-nurown
Reported Earlier, BrainStorm Cell Therapeu...
04/17/2024 06:54:01

Bob Dagher, MD, Promoted to Chief Medical Officer Dr. Stacy Lindborg Stepping Down as Co-CEO and Transitioning to Board of D...

brainstorm-cell-therapeutics-regains-compliance-with-nasdaq-minimum-market-value-rule
BrainStorm Cell Therapeutics Regains Compl...
04/11/2024 10:02:49

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI, ", , the Company", , )))), a leading developer of cellular therapies fo...

brainstorm-cell-therapeutics-announced-peer-reviewed-publication-of-phase-3-biomarker-data-in-muscle-and-nerve-suggesting-that-debamestrocel-or-nurown-may-impact-key-biomarkers-in-amyotrophic-lateral-sclerosis-that-are-predictive-of-disease-progression
Brainstorm Cell Therapeutics Announced Pee...
04/10/2024 10:02:28

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 12:09:53

why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket
Why Biophytis Shares Are Trading Higher By...
04/09/2024 10:05:24

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

brainstorm-cell-therapeutics-received-written-agreement-from-fda-under-special-protocol-assessment-on-design-for-phase-3b-trial-of-nurown-in-amyotrophic-lateral-sclerosis-expected-to-start-in-2024
Brainstorm Cell Therapeutics Received Writ...
04/09/2024 10:02:50

brainstorm-cell-q4-eps-011-beats-015-estimate
Brainstorm Cell Q4 EPS $(0.11) Beats $(0.1...
04/01/2024 19:47:53

Brainstorm Cell (NASDAQ:BCLI) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.1...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/01/2024 16:31:03

brainstorm-cell-q4-earnings-insights
Brainstorm Cell: Q4 Earnings Insights
04/01/2024 14:35:08

brainstorm-cell-therapeutics-reported-fy23-eps-loss-of-040-cash-balance-of-145m
BrainStorm Cell Therapeutics Reported FY23...
04/01/2024 12:08:10

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/25/2024 21:32:19

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/20/2024 17:31:24

brainstorm-cell-therapeutics-has-been-granted-israeli-patent-number-277447-titled-cell-type-specific-exosomes-and-use-thereof-for-the-treatment-of-neurodegenerative-diseases
Brainstorm Cell Therapeutics Has Been Gran...
03/05/2024 17:17:51

https://israelpatents.justice.gov.il/search/en/patent-extract/277447

brainstorm-cell-therapeutics-will-present-a-poster-outlining-the-proposed-design-for-a-phase-3b-trial-of-nurown-in-amyotrophic-lateral-sclerosis-at-the-mda-clinical-and-scientific-conference-on-monday
Brainstorm Cell Therapeutics Will Present ...
02/27/2024 11:39:56

 The design is for a two-part, multicenter, Phase 3b study to assess the efficacy and safety of NurOwn in participants with ALS...

brainstorm-cell-therapeutics-submits-special-protocol-assessment-spa-request-to-fda-for-phase-3b-trial-of-nurown-in-amyotrophic-lateral-sclerosis
Brainstorm Cell Therapeutics Submits Speci...
02/23/2024 11:06:39

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
02/21/2024 21:31:09

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/19/2024 13:05:48

why-ups-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why UPS Shares Are Trading Lower By 8%? He...
01/30/2024 18:18:27

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-e...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
01/22/2024 21:31:12

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION